For persons diagnosed with HIV aged 50 years and older, progress on quality of life goals is limited, according to study findings.

Implementation of opt-out ED syphilis screening leads to a dramatic increase in screening and diagnosis, especially among pregnant individuals.

Researchers determined persistence of iron deficiency was common in patients with an iron deficiency diagnosis.

Twice-yearly lenacapavir was found to be superior to daily emtricitabine 200mg and tenofovir disoproxil fumarate 300mg.

Self-compassion among adolescents and young adults with inflammatory bowel diseases may lead to better psychosocial and physical health.

A single dose of chikungunya vaccine is safe, effective, provides protection up to 2 years, and does not result in any long-term serious AEs related to vaccination.

Statistics from 2023 on United States obesity rates reveal that in every US state, 1 in every 5 people now has obesity.

A study investigating GSK’s investigational herpes simplex virus (HSV) vaccine candidate failed to meet its primary efficacy endpoint.

Language barrier may reduce a patient’s ability to convey cardiac vs noncardiac chest pain, thereby adversely impacting his or her health care experience.

It could be a real breakthrough for people at risk for HIV infection: A shot given every 6 months that reduces their risk by a whopping 96%.

The FDA has approved Tremfya® (guselkumab) for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).

HPV vaccination was highly effective against anal HPV in a cohort of HIV-negative MSM, particularly when vaccination occurred at younger ages.